A Study to Evaluate the Pharmacokinetics, Efficacy, and Safety of HLX319 vs. EU-Phesgo® in the Neoadjuvant Therapy of HER2-Positive Early or Locally Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Clinical Trials Related to Shanghai Henlius Biotech
Related studies linked through entity extraction aliases.
A Phase I Multicentre Randomized Double-Blind Parallel-Controlled Study of HLX05-N vs. ERBITUX® in Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Phase I Clinical Study of HLX316 in Participants With Advanced/Metastatic Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Phase I Clinical Study of HLX3902 in Patients With mCRPC and Other Advanced Tumours
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Pharmacokinetic Characteristics, Safety, and Immunogenicity of HLX319 Compared With EU-Phesgo®
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase II Study of HLX43 Monotherapy or Combined With Immune Checkpoint Inhibitors in Patients With Locally Advanced, Recurrent, or Metastatic Triple-negative Breast Cancer.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, PK, and Immunogenicity of Recombinant Human Hyaluronidase in Healthy Subjects
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HLX97 (a KAT6A/B Inhibitor) in Patients With Advanced/Metastatic Solid Tumor
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and PK of HLX48 in Advanced/Metastatic Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Global Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX43 Monotherapy or HLX43 in Combination With HLX07 Versus Docetaxel in Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Phase II Study to Evaluate the Efficacy and Safety of HLX43 in Patients With Hormone Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced SCLC or NEC
- Status
- RECRUITING
- Phase
- PHASE1
A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1